What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His main research concerns Immunology, Cell biology, Inflammation, Chemokine and Cytokine.
The various areas that Alberto Mantovani examines in his Immunology study include Cancer research and Macrophage.
The Cell biology study combines topics in areas such as Receptor, Chemotaxis, Chemokine receptor and Macrophage polarization.
His study on Inflammation also encompasses disciplines like
- Cancer that connect with fields like Angiogenesis,
- Immune system that connect with fields like Effector.
His Chemokine study combines topics from a wide range of disciplines, such as Endocrinology, Decoy receptors, In vivo and Monocyte.
Alberto Mantovani focuses mostly in the field of Cytokine, narrowing it down to matters related to Tumor necrosis factor alpha and, in some cases, Lipopolysaccharide.
His most cited work include:
- Cancer-related inflammation. (6651 citations)
- Inflammation and cancer: back to Virchow? (5144 citations)
- The chemokine system in diverse forms of macrophage activation and polarization. (4151 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Inflammation, Cell biology, Internal medicine and PTX3.
His Immunology study frequently draws connections to other fields, such as Receptor.
His Inflammation research is multidisciplinary, relying on both Acquired immune system, Cancer and Cancer research, Angiogenesis.
Alberto Mantovani works in the field of Cell biology, focusing on Signal transduction in particular.
His PTX3 research is multidisciplinary, incorporating perspectives in Serum amyloid P component and C-reactive protein.
His studies in Chemokine integrate themes in fields like Chemotaxis and Monocyte.
He most often published in these fields:
- Immunology (40.15%)
- Inflammation (23.86%)
- Cell biology (25.01%)
What were the highlights of his more recent work (between 2016-2021)?
- Inflammation (23.86%)
- Food science (5.78%)
- Feed additive (5.20%)
In recent papers he was focusing on the following fields of study:
Alberto Mantovani mainly focuses on Inflammation, Food science, Feed additive, Cancer research and Immunology.
His Inflammation study incorporates themes from Receptor, Innate immune system, Immune system and Cell biology.
Alberto Mantovani is studying Chemokine receptor, which is a component of Receptor.
In his research, Recombinant DNA is intimately related to Genetically modified organism, which falls under the overarching field of Food science.
He has included themes like Chemokine, Cancer, Tumor progression and Macrophage in his Cancer research study.
His PTX3 research is within the category of Internal medicine.
Between 2016 and 2021, his most popular works were:
- Tumour-associated macrophages as treatment targets in oncology (1121 citations)
- Metabolism disrupting chemicals and metabolic disorders (354 citations)
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Alberto Mantovani spends much of his time researching Inflammation, Cancer research, Immunology, Innate immune system and Immune system.
Alberto Mantovani interconnects Carcinogenesis, Cancer, Receptor and Cell biology in the investigation of issues within Inflammation.
He combines subjects such as Acquired immune system and Transcription factor with his study of Cell biology.
The study incorporates disciplines such as Chemokine, Cytotoxic T cell, Adoptive cell transfer and Metastasis in addition to Cancer research.
His works in Interleukin and Complement system are all subjects of inquiry into Immunology.
The concepts of his Innate immune system study are interwoven with issues in Epigenetics, Macrophage and Immunity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
